mutations and sophisticated kar yotype. It follows a linear evolution through the CLL clone with the recurrent acquisition of CDKN2ANot all patients with CLL involve therapy. In spite of all recent improvements, the iwCLL still endorses watchful observation for people with asymptomatic illness.86 This suggestion relies on a minimum of two randomize